| 期 |
栏目 |
标题 |
文件 |
| 卷 79, 编号 7 (2004) |
Editorial |
Molecular-cytogenetic monitoring of different regimens of treatment |
|
| 卷 79, 编号 7 (2004) |
Editorial |
Prediction of interferon therapy efficacy in chronic myeloid leukemia according to histomorphological evidence |
|
| 卷 79, 编号 7 (2004) |
Editorial |
Glivek in therapy of some forms of Ph- and bcr/abl-negative myeloproliferative diseases and a myeloproliferative variant of idiopathic hypereosinophilic syndrome |
|
| 卷 82, 编号 2 (2010) |
Editorial |
A rare complication of imatinib mesylate therapy: drug-induced pneumonitis |
|
| 卷 85, 编号 7 (2013) |
Editorial |
Therapeutic strategy for chronic myeloid leukemia: possibilities and prospects |
|
| 卷 86, 编号 7 (2014) |
Editorial |
Incidence of chronic myeloid leukemia in 6 regions of Russia according to the data of the 2009-2012 population-based study |
|
| 卷 86, 编号 7 (2014) |
Editorial |
Synchronous and metachronous myeloid and lymphoid tumors |
|
| 卷 87, 编号 12 (2015) |
Editorial |
FIP1L1-PDGFRА-positive myeloproliferative disease with eosinophilia: A rare case with multiple organ dysfunction and a response to tyrosine kinase inhibitor therapy |
|
| 卷 88, 编号 7 (2016) |
Editorial |
A rare case of myeloproliferative disease with t(8;13)(p11;q12) associated with eosinophilia and lymphadenopathy |
(Rus)
|
| 卷 88, 编号 12 (2016) |
Editorial |
Efficiency of interferon therapy in patients with essential thrombocythemia or polycythemia vera |
(Rus)
|
| 卷 89, 编号 12 (2017) |
Editorial |
Results of following up patients with chronic myeloid leukemia and a deep molecular response without tyrosine kinase inhibitor therapy |
|
| 卷 78, 编号 8 (2003) |
Editorial |
Therapeutic efficacy of imatinibmesilate (glivek) in chronic phase of myeloid leukemia |
|
